Companies / Jasper Therapeutics Inc
Jasper Therapeutics Inc
Nasdaq: JSPRCIK 1788028REDWOOD CITY, CA
Financials
Ownership
28.0M shares outstanding · as of May 11, 2026
Ownership
| Institutions | 75.58% | 21,161,089 |
| Public float | 24.42% | 6,835,730 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 3
View all →| Insider | % of shares | Shares |
|---|---|---|
Cross HerbChief Financial Officer | — | — |
Mahal Jeetinder SinghCEOFormerCEO and President · Director | — | — |
Martell RonCEOFormerPresident, CEO and Director · Director | — | — |
Institutional holders 63
View all →| Holder | Value | % of shares |
|---|---|---|
| $4.88M | 9.53% | |
| $3.60M | 7.04% | |
| $3.27M | 6.38% | |
| $3.20M | 6.24% | |
| $2.43M | 4.74% | |
| $2.01M | 3.93% | |
| $1.90M | 3.72% | |
| $1.45M | 2.84% | |
| $1.42M | 5.78% | |
| $1.18M | 4.83% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Kingdon Capital Management, L.L.C. 13F manager | New | Common Stock | $1.18M | +1.4M | 1,352,106 4.83% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | Add | Common Stock | $476.4K | +544K +50.64% | 1,617,531 5.78% of shares | low |
| Q1 2024 as of | Leonteq Securities AG 13F manager | New | Common Stock | $234.9K | +8K | 8,000 0.03% of shares | low |
| Q3 2024 as of | Barclays PLC 13F manager | Add | Common Stock | $231.5K | +12K +320.69% | 16,146 0.06% of shares | low |
| Q1 2025 as of | Leonteq Securities AG 13F manager | Exit | Common Stock | $-171.0K | -8K -100.00% | — | low |
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | Exit | Common Stock | $-123.1K | -67K -100.00% | — | low |
| Q2 2025 as of | Barclays PLC 13F manager | Trim | Common Stock | $-107.8K | -18K -99.99% | 1 <0.01% of shares | low |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common Stock | $92.7K | +106K +49.95% | 317,677 1.13% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Integrated Core Strategies (US) LLC | Passive13G | — |
| Acorn Bioventures, L.P. | Passive13G/A | — |
| Morgan Stanley | Passive13G | — |
| The Goldman Sachs Group, Inc. | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| JSPR | Common Stock | 471871202 |